 |
 |
|
|
|
| Gonadorelin Acetate |
 |
| C55H75N17O13 |
 |
| 71447-49-9 |
 |
It is clinically used to treat carcinoma of prostate.
|
 |
Parameters of Product:
1 .Appearance :White powder
2 .Specific Optical Rotation [a]eq \o(\s\up 6(20),\s\do 2( D))20 D(c=1,1% HAc) : -55.0~-65.0°
3 .Water Content(Karl Fischer) :≤8.0%
4 .Acetate Content(by HPLC) :≤10.0%
5 .Amino Acid Composition :±10% of theoretical
6 .Purity (by HPLC) :≥98.0%
7 .Single Impurity(by HPLC) :≤1.0%
8 .Peptide Content(by %N) :≥80%
9 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0%
10 Becterial Endotoxins :≤5EU/mg
|
|
|
|
|
|
